Higher vitamin D levels associated with better outcomes in breast cancer survivors

November 10, 2016
breast cancer
Mammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public Domain

Women with higher vitamin D levels in their blood following a breast cancer diagnosis had significantly better long-term outcomes, according to new research from Kaiser Permanente and Roswell Park Cancer Institute. The study was published online today in JAMA Oncology.

Vitamin D is a nutrient best known for its role in maintaining healthy bones; conversely, vitamin D deficiency has been associated with the risk for several cancers.

Common sources of vitamin D include sun exposure, fatty fish oils, vitamin supplements, and fortified milks and cereals. While the mechanisms for how vitamin D influences outcomes are not well understood, researchers believe it may be related to its role in promoting normal mammary-cell development, and inhibiting the reproduction of and promoting the death of cancer cells.

"We found that women with the highest levels of vitamin D levels had about a 30 percent better likelihood of survival than women with the lowest levels of vitamin D," said Lawrence H. Kushi, ScD, research scientist with the Kaiser Permanente Northern California Division of Research and principal investigator of Kaiser Permanente's Pathways study of breast cancer survivorship. The current study included 1,666 Pathways study members who provided samples between 2006 and 2013.

With funding from the National Cancer Institute, the Pathways study began enrolling Kaiser Permanente members in Northern California who had a diagnosis of invasive breast cancer in 2006. Participants provided blood samples within two months of diagnosis and answered questions about diet, lifestyle and other risk factors, with follow-ups at six months and at two, four, six and eight years.

"With the extremely rich data sources from a large sample size, we were able to prospectively analyze three major breast cancer outcomes—recurrence, second primary cancer and death," said Song Yao, PhD, associate professor of oncology at Roswell Park Cancer Institute and the study's lead author. The institute, located in Buffalo, NY, is a partner in the Pathways study.

"We were also able to adjust for multiple possible contributing factors that could influence vitamin D levels," Yao said, "such as age, obesity, race and ethnicity, socioeconomic status, and several tumor characteristics that are known to influence breast cancer outcomes—to ensure that the effects we observed were independent of these factors."

In addition to lower overall mortality among all breast cancer survivors studied, the researchers found even stronger associations among premenopausal women in the highest third of vitamin D levels for breast-cancer-specific (63 percent better), recurrence-free (48 percent better) and invasive-disease-free survival (42 percent better), during a median follow up of seven years.

Although the study did not examine the effects of vitamin D intake from foods versus supplements, Kushi noted that it supports the recommended daily levels of vitamin D (600 IU for those 1 to 70 years old and pregnant or breastfeeding women, and 800 IU for those over 71 years old).

"The more we know about vitamin D, the more we understand that it may play a key role in cancer prevention and prognosis," Kushi said. "This study adds to the evidence that vitamin D is an important nutrient."

The National Cancer Institute recently awarded a five-year, $10 million grant to Kaiser Permanente and Roswell Park Cancer Institute, co-led by Kushi and Christine Ambrosone, PhD, senior vice president for population sciences at Roswell Park and a key collaborator on the D research. The new funding will allow researchers to continue following Pathways participants, establish a biorepository of tumor specimens, conduct germline genetic assessments, and obtain more information about the characteristics of neighborhoods in which the women reside.

This study is part of Kaiser Permanente's ongoing efforts to understand the complexities associated with breast cancer survival and outcomes. For example, last year Kaiser Permanente researchers found a lower risk of recurrence in patients who breastfed and among those with specific HER2 positive tumors. In addition, in two separate studies published in 2013 researchers found that with strong social networks had a lower risk of mortality, while those who consumed high-fat dairy products had a higher mortality risk.

Explore further: Vitamin D influences racial differences in breast cancer risk

More information: JAMA Oncol. Published online November 10, 2016. DOI: 10.1001/jamaoncol.2016.4188

Related Stories

Vitamin D influences racial differences in breast cancer risk

April 4, 2012

American women of African ancestry are more likely than European Americans to have estrogen receptor (ER) negative breast cancer. There continues to be discussion about the role of low levels of vitamin D in the development ...

Recommended for you

Bringing evidence to health screening debates

February 19, 2017

Whether to screen? How often? At what age? At what cost?—seem to readily breed conflicting opinions and public confusion. What's needed is rigorously produced evidence. That's where Constantine Gatsonis, chair of the Department ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.